Benjamin (Hrsg.) Bonavida
YY1 in the Control of the Pathogenesis and Drug Resistance of Cancer
A Critical Therapeutic Target
Ebook (EPUB Format)
YY1 Is Pivotal in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target describes the current state-of-the-art of the transcription factor YY1 that is overexpressed in the majority of cancers and a central factor that regulates all of the major features and characteristics of human cancers. This book emphasizes the biochemical, molecular and genetic underlying mechanisms by which YY1 regulates its pro-cancerous activities. In addition, it also describes the role of YY1 in the regulation of tumor cell resistance to conventional chemo and immunotherapies and the important role of inhibiting YY1 in cancer.…
Mehr
Beschreibung
YY1 Is Pivotal in the Control of the Pathogenesis and Drug Resistance of Cancer: A Critical Therapeutic Target describes the current state-of-the-art of the transcription factor YY1 that is overexpressed in the majority of cancers and a central factor that regulates all of the major features and characteristics of human cancers. This book emphasizes the biochemical, molecular and genetic underlying mechanisms by which YY1 regulates its pro-cancerous activities. In addition, it also describes the role of YY1 in the regulation of tumor cell resistance to conventional chemo and immunotherapies and the important role of inhibiting YY1 in cancer. This book is a valuable source for cancer researchers, oncologists and several members of medical and biomedical field who are interested in understanding further the role of YY1 in cancer.Provides a thorough understanding of the underlying mechanisms by which YY1 regulates cancer cell phenotype and unique characteristicsDiscusses the novel mechanisms of YY1 regulation of tumor cell resistance and means to overcome resistanceEncompasses new examples of newly developed non-toxic and selective inhibitors targeting YY1
CHF 199.95
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
- ISBN: 978-0-12-822636-0
- EAN: 9780128226360
- Produktnummer: 35965571
- Verlag: Elsevier Science & Techn.
- Sprache: Englisch
- Erscheinungsjahr: 2020
- Seitenangabe: 360 S.
- Plattform: EPUB
- Masse: 25'915 KB
34 weitere Werke von Benjamin (Hrsg.) Bonavida:
A Critical Therapeutic Target
Ebook (PDF Format)
CHF 165.50
A Critical Therapeutic Target
Ebook (PDF Format)
CHF 154.50
A Critical Therapeutic Target
Ebook (EPUB Format)
CHF 169.00
A Critical Therapeutic Target
Ebook (PDF Format)
CHF 165.50
A Critical Therapeutic Target
Ebook (EPUB Format)
CHF 169.00
A Critical Therapeutic Target
Ebook (EPUB Format)
CHF 212.85
A Critical Therapeutic Target
Ebook (EPUB Format)
CHF 169.00
A Critical Therapeutic Target
Ebook (PDF Format)
CHF 187.50
A Critical Therapeutic Target
Ebook (PDF Format)
CHF 165.50
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.